How to Use & Interpret a Continuous Glucose Monitor (CGM)

Continuous Glucose Monitors: A Practical Guide From Huberman Lab

Continuous glucose monitors (CGMs) have gone from niche diabetes tools to mainstream health trackers. This Huberman Lab clip breaks down how to use and interpret the data from a CGM, and it does so with the kind of detail that makes the device actually useful rather than just another gadget collecting dust in your nightstand drawer.

A CGM is a small sensor (usually worn on the back of the arm) that measures interstitial glucose levels every 1-5 minutes and sends the data to your phone. The result is a continuous stream of blood sugar data that reveals patterns invisible to traditional fingerstick testing. Instead of seeing a snapshot 2-4 times per day, you see the complete movie of your metabolic response to food, exercise, stress, and sleep.

The clip covers the practical basics: where to place the sensor, how long each sensor lasts (typically 10-14 days depending on brand), the lag time between blood glucose and interstitial glucose (about 10-15 minutes, which matters during rapid changes), and how to calibrate if your device requires it. These details sound boring but they're the difference between accurate data and misleading noise.

Reading the Glucose Curves: What They Actually Mean

The most useful part of this video is the interpretation guidance. A CGM gives you a continuous trace, but knowing what to do with that trace is what turns data into insight. The discussion covers several key patterns:

Post-meal spikes: A glucose rise after eating is normal. The question is how high it goes and how quickly it comes back down. A healthy response is a rise of 30-40 mg/dL above baseline, peaking 30-60 minutes after eating, and returning to baseline within 2 hours. If your spikes regularly exceed 50-60 mg/dL above baseline or take more than 2-3 hours to resolve, your insulin response isn't keeping up, which is an early sign of insulin resistance.

Dawn phenomenon: Many people see their glucose rise in the early morning hours, even without eating. This is caused by cortisol and growth hormone release that signal the liver to produce glucose. A modest dawn rise (10-20 mg/dL) is normal. A large rise suggests that the liver's glucose production isn't being properly checked by insulin, another marker of metabolic dysfunction.

Exercise responses: Blood sugar typically drops during moderate-intensity exercise (walking, cycling) but can spike during high-intensity exercise (sprinting, heavy lifting) due to adrenaline-driven glucose release from the liver. Both responses are normal. What matters is how quickly glucose returns to baseline after the activity.

What the Video Gets Right

The pattern-recognition framework is excellent. Rather than telling viewers "your blood sugar should be between 70 and 140 all the time," the discussion contextualizes what's normal versus concerning based on the situation. Post-meal, you expect a rise. During exercise, you expect variability. Overnight, you expect stability. This nuanced approach prevents unnecessary anxiety from normal glucose fluctuations.

The emphasis on using CGM data to make dietary experiments is also smart. Try a meal, see the response, adjust the composition or portion size, and try again. This empirical approach is far more effective than following generic dietary advice because individual responses vary enormously. Two people can eat the same meal and have completely different glucose curves.

What's Missing

The video doesn't adequately address the limitations of CGMs for non-diabetic users. The accuracy of these devices is optimized for the diabetic range (above 180 mg/dL), and in the normal range (70-120 mg/dL), the measurement error can be significant enough to create false patterns. A reading of 68 mg/dL might actually be 80 mg/dL, and panicking about a "low" that isn't real is counterproductive.

There's also limited discussion of the psychological impact. Some people become obsessive about their glucose numbers, developing what clinicians have called "data anxiety." If you find yourself checking your CGM every 10 minutes and reorganizing your entire life around keeping the line flat, the device may be doing more harm than good. A brief mention of healthy versus unhealthy relationships with glucose data would have been valuable.

Questions for Your Doctor About CGMs

Whether you have diabetes or are just metabolically curious:

Ask whether a CGM is appropriate for your situation. For diabetic patients on insulin, it's a near-requirement. For pre-diabetic patients, it can be a powerful motivational and educational tool. For metabolically healthy people, a 2-4 week trial can provide useful insights but may not need to be ongoing. Ask which CGM brand and model your doctor recommends. Dexcom, Libre, and other options differ in accuracy, ease of use, and app features.

Ask about insurance coverage. CGMs are typically covered for type 1 and insulin-dependent type 2 diabetes. Coverage for other populations varies. Some pharmacies offer Libre sensors over the counter without a prescription. Ask about interpretation. If your doctor isn't familiar with CGM data analysis, ask for a referral to a diabetes educator or endocrinologist who can help you make sense of the patterns. Ask how long you should wear one to get useful data. For most people, 2-4 weeks provides enough information to identify major patterns and make dietary adjustments.

The Variability Factor: Why Your Results Differ From Everyone Else's

One of the most eye-opening discoveries for many CGM users is how dramatically glucose responses vary between individuals. A study from the Weizmann Institute of Science demonstrated that two people eating identical meals can have completely different glucose responses. One person might spike 60 mg/dL after eating a banana while barely budging after eating a cookie. The other person might show the opposite pattern. These differences are driven by gut microbiome composition, genetics, body composition, sleep patterns, stress levels, and recent exercise, among other factors. The practical implication is that generic dietary advice ("eat more whole grains," "avoid sugar") may not apply equally to everyone, and a CGM lets you discover your personal responses rather than relying on population averages.

This personalized approach is particularly relevant for people on GLP-1 drugs, because the medication itself changes your glucose response. A meal that spiked your blood sugar 50 mg/dL before starting semaglutide might only cause a 20 mg/dL rise on the medication, because the slowed gastric emptying and enhanced insulin secretion smooth out the absorption curve. Seeing this difference on a CGM provides tangible evidence that the medication is working, which can be motivating. It also helps you identify which foods still cause problematic spikes even on medication, guiding further dietary refinement.

The Stress Response: What Your CGM Reveals About Non-Food Triggers

One of the most underappreciated aspects of CGM data is what it reveals about non-food glucose triggers. Stress, both physical and psychological, causes cortisol and adrenaline release, which stimulate the liver to release glucose as part of the fight-or-flight response. Many CGM users are surprised to see their blood sugar rise during work stress, arguments, or even exciting movies, despite not having eaten anything. For GLP-1 users, understanding these non-food triggers is important because they explain glucose variability that can't be managed through dietary changes alone.

Poor sleep is another major non-food glucose disruptor. Even one night of inadequate sleep (less than 6 hours) can increase insulin resistance the following day, leading to higher post-meal glucose spikes. Over time, chronic sleep deprivation compounds this effect and can significantly impair the effectiveness of GLP-1 drugs and other diabetes medications. If your CGM consistently shows higher glucose levels on days following poor sleep, that's actionable data that might motivate investing in sleep quality. Similarly, illness, menstrual cycle hormonal shifts, and certain medications (like corticosteroids) can affect glucose levels in ways that become visible on CGM data. Understanding these patterns helps you respond appropriately rather than blaming yourself for glucose variability that's driven by factors beyond your dietary choices.

Cost and Practicality for Different Patient Groups

CGMs range in cost from about $75-150 per month for over-the-counter options (like the Dexcom Stelo or Libre sensors available without prescription) to zero out-of-pocket for insured patients with insulin-dependent diabetes. For non-diabetic or pre-diabetic users, insurance coverage is rare, and the out-of-pocket cost needs to be weighed against the information value. A reasonable approach for this group is a 2-4 week trial period to learn your personal glucose patterns, followed by periodic re-evaluation every 6-12 months to track changes. Continuous long-term CGM use is probably unnecessary for people with normal glucose regulation, as the patterns you identify in the first few weeks tend to be consistent over time.

For GLP-1 Users Specifically: What a CGM Tells You About Your Medication

If you're on a GLP-1 drug, wearing a CGM for even a few weeks can provide uniquely valuable insights. You can see the medication's effect on post-meal glucose spikes in real time. The flattened post-meal curves that most GLP-1 users experience are visible proof that the medication is working, which can be motivating. You can also identify meals or food combinations that still cause significant spikes despite the medication, guiding further dietary optimization. Some patients discover that specific foods (pasta, white rice, fruit juice) cause disproportionate spikes even on semaglutide, and adjusting these specific items produces better overall glucose control than broad dietary restrictions.

The CGM data can also help with dose optimization discussions with your doctor. If your glucose traces show excellent post-meal control but frequent mild lows, your GLP-1 dose might be higher than necessary. If you're seeing good fasting glucose but persistent post-meal spikes above 160 mg/dL, the dose might need to increase or you might benefit from timing meals differently relative to your injection day. This kind of precision dosing, informed by continuous glucose data rather than periodic lab tests, represents a more sophisticated approach to GLP-1 therapy that produces better outcomes with fewer side effects.

Who Should Watch This

Anyone considering or currently wearing a CGM should watch this. It's especially useful for people who have the device but don't know how to interpret the data beyond "high is bad, low is bad." The nuanced pattern discussion transforms a CGM from a source of anxiety into a genuinely useful health tool. GLP-1 drug users will find particular value because a CGM lets you see in real time how the medication is affecting your glucose response to meals, which is both motivating and clinically useful for dose optimization.